SCI时时刷

search
+
Early access programs for medicines: a reform proposal for the Italian National Health Service
Popoli, P., Giuliani, G., Cavaliere, A., & Jommi, C. (2024). Early access programs for medicines: a reform proposal...
How effective are prescriptive governance tools? Results from the application of AIFA notes
Agenzia Italiana del Farmaco (AIFA). Note AIFA | [Internet]. (Accessed September 2023) Online: https...
Gender differences and hypercholesterolemia: real-world evidence from the study WECARE (Women Effective CArdiovascular Risk Evaluation)
Gender differences and hypercholesterolemia: real-world evidence from the study WECARE (Women Effective CArdiovascular ...
The economic impact of 14 compassionate use programs for medicines in Italy, in the perspective of the National Health Service
Polak TB, van Rosmalen J, Uyl-de Groot CA. Expanded Access as a source of real-world data: an overvi...
Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders
Vanselow S, Wahn V, Schuetz C. Activated PI3Kδ syndrome – reviewing challenges in diagnosis and trea...
Patient-reported outcomes in epilepsy: a case study exploring their usage and impact
Food and Drug Administration. U.S. Department of Health and Human Services. Patient-Reported Outcome...
Costs and benefits in patients with NYHA class III heart failure treated with CardioMEMS in Italy
Brugts JJ, Radhoe SP, Clephas PRD, et al; MONITOR-HF investigators. Remote haemodynamic monitoring o...
Regional administrative data and their role in planning, programming and controlling at regional level
Marzona, I., Stella, P., Trifirò, G., & Corrao, G. (2024). Regional administrative data and their role in planning,...
Heart failure and economic impact: an analysis in real clinical practice in Italy
Watson RD, Gibbs CR, Lip GY. ABC of heart failure. Clinical features and complications. BMJ. 2000;32...
The socioeconomic burden of adult attention-deficit/hyperactivity disorder in Spain
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ...
The role and impact of health economics in the optimization of patient care in osteoarthritis: insights from a practical example
Vos T, Lim SS, Abbafati C, et al; GBD 2019 Diseases and Injuries Collaborators. Global burden of 369...
Regional Formularies in Italy: current state and future perspectives
Jommi C, Pippo L, Bortolami A et al. Il governo dell’assistenza farmaceutica in Italia: il ruolo di ...
Cost per Number Needed to Treat (NNT) for upadacitinib in the treatment of bio-exposed patients with moderately-severely active ulcerative rectocolitis
Burr NE, Gracie DJ, Black CJ, Ford AC. Efficacy of biological therapies and small molecules in moder...
HTA regulation: how is Italy moving?
Authors Francesca Patarnello Vice-President Market Access ...
Cost per NNT for upadacitinib in the treatment of patients with moderate-severe atopic dermatitis in Italy
Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396(10247):345-360. https://doi.o...
Clinical and economic burden of peristomal skin complications: Activity Based Costing analysis
Robertson I, Leung E, Hughes D, et al. Prospective analysis of stoma-related complications. Colorect...
Italian healthcare resource consumption for patients on hemodialysis treated for chronic kidney disease-associated pruritus (CKD-aP)
Sukul N, Karaboyas A, Csomor PA, et al. Self-reported pruritus and clinical, dialysis-related, and p...
The future of drugs distribution in the National Health System
Osservatorio Farmaci Cergas, Università Bocconi. Report n. 42 – Report annuale per il 2021 https://c...
A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas
Chanson P, Maiter D. The epidemiology, diagnosis and treatment of prolactinomas: the old and the new...
Orphan drugs in Italy: availability and time-to-access at regional level
European Medicines Agency. Human regulatory. Orphan designation. https://www.ema.europa.eu/en/human-...
Time to market access in Italy: duration of the P&R process for rare disease drugs
Kwon HY, Kim H, Godman B. Availability and Affordability of Drugs With a Conditional Approval by the...
Cost-effectiveness analysis of abemaciclib with endocrine therapy (ET) versus ET alone for HR+, HER2−, node-positive, high-risk early breast cancer in Italy
Cancer.Net. Breast cancer: statistics. https://www.cancer.net/cancer-types/breast-cancer/statistics....
Unmet need: definitions, literature evidence and implications for HTA
Caprari F, Alfano A, Buzzetti G, et al. [Unmet clinical need and new therapeutic options.]. Recenti ...
Good practices for the development of budget impact models at regional level
Linee guida per la compilazione del dossier a supporto della domanda di rimborsabilità e prezzo di u...
COVID-19 impact on the decision process of the Italian Medicine Agency: a quantitative assessment
Guidelines for pricing and reimbursement of medicines (determina DG/1372/2020) [Internet]. Agenzia I...
Price and reimbursement of medicines when new indications are approved: the results of a survey on ISPOR Italy Rome Chapter members
Preckler V, Espín J. The Role of Indication-Based Pricing in Future Pricing and Reimbursement Polici...
Budget impact analysis of enzalutamide for the treatment of hormone-sensitive metastatic prostate cancer in Italy
AIOM: Linee guida del Carcinoma della Prostata. 2021. Online https://snlg.iss.it/wp-content/uploads/...
Cost-effectiveness of IMI/CIL/REL for the treatment of carbapenem non-susceptible Gram-negative bacterial infections
Cassini A, Högberg LD, Plachouras D, et al; Burden of AMR Collaborative Group. Attributable deaths a...
The role of patient-reported outcomes in reimbursement decisions and drug innovation in Italy
Brogan AP, DeMuro C, Barrett AM, D’Alessio D, Bal V, Hogue SL. Payer Perspectives on Patient-Reporte...
Cost-minimization analysis to support the HTA of Radiofrequency Echographic Multi Spectrometry (REMS) in the diagnosis of osteoporosis
Consensus development conference. Consensus development conference: diagnosis, prophylaxis, and trea...
阅读更多
format_indent_increase